GSH attenuates organ injury and improves function after transplantation of fatty livers

European Surgical Research

Volumn 45, Issue 1, 2010, Pages 13-19

  Pratschke, S ^a   Angele, M K ^a   Grutzner U ^a   Tufman, A ^a   Bilzer, M ^a   Loehe, F ^a   Jauch, K W ^a   Schauer, R J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fatty liver; Glutathione; Organ injury; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TATIONIL 600; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE FLOW; BLOOD SAMPLING; CONTROLLED STUDY; FATTY LIVER; HISTOLOGY; LIVER FUNCTION; LIVER GRAFT; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 77955103427     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316643     Document Type: Article

References (40)

1. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al: Use of fatty donor liver is associated with dimin-ished early patient and graft survival. Trans-plantation 1996; 62: 1246-1251.
2. Koneru B, Dikdan G: Hepatic steatosis and liver transplantation current clinical and ex-perimental perspectives. Transplantation 2002; 73: 325-330.
3. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA: Use of severely steatotic grafts in liver transplanta-tion: a matched case-control study. Ann Surg 2007; 246: 940-946.
4. Angele MK, Rentsch M, Hartl WH, Witt-mann B, Graeb C, Jauch KW, et al: Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008; 195: 214-220.
5. Soltys K, Dikdan G, Koneru B: Oxidative stress in fatty livers of obese Zucker rats: rap-id amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001; 34: 13-18.
6. Amersi F, Shen XD, Moore C, Melinek J, Busuttil RW, Kupiec-Weglinski JW, et al: Fi-bronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury. Am J Pathol 2003; 162:1229-1239.
7. Bilzer M, Paumgartner G, Gerbes AL: GSH protects the rat liver against reperfusion in-jury after hypothermic preservation. Gas-troenterology 1999; 117:200-210.
8. Jaeschke H: Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006; 290:G1083-G1088.
9. Bilzer M, Baron A, Schauer R, Steib C, Ebensberger S, Gerbes AL: GSH treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation. Digestion 2002; 66:49-57.
10. Schauer RJ, Kalmuk S, Gerbes AL, Leiderer R, Meissner H, Schildberg FW, et al: Intrave-nous administration of GSH protects paren-chymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004; 10:864-870.
11. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA: Mechanisms of ischemic in-jury are different in the steatotic and normal rat liver. Hepatology 2000; 32:1280-1288.
12. Amersi F, Farmer DG, Shaw GD, Kato H, Coito AJ, Kaldas F, et al: P-selectin glycopro-tein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat stea-totic liver grafts from ischemia/reperfusion injury. Am J Transplant 2002; 2:600-608.
13. Bradham CA, Schemmer P, Stachlewitz RF, Thurman RG, Brenner DA: Activation of nu-clear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 1999; 5: 282-293.
14. Schemmer P, Bradford BU, Rose ML, Bun-zendahl H, Raleigh JA, Lemasters JJ, et al: In-travenous glycine improves survival in rat liver transplantation. Am J Physiol 1999; 276:G924-G932.
15. Kamada N, Calne RY: A surgical experience with 530 liver transplants in the rat. Surgery 1983; 93: 64-69.
16. Post S, Gonzalez AP, Palma P, Rentsch M, Stiehl A, Menger MD: Assessment of hepatic phagocytic activity by in vivo microscopy af-ter liver transplantation in the rat. Hepatol-ogy 1992; 16: 803-809.
17. Schauer RJ, Bilzer M, Kalmuk S, Gerbes AL, Leiderer R, Schildberg FW, et al: Microcircu-latory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation 2001; 72:1692-1699.
18. Jaeschke H, Mitchell JR: Use of isolated per-fused organs in hypoxia and ischemia/reper-fusion oxidant stress. Methods Enzymol 1990; 186: 752-759.
19. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized GSH: applications to mamma-lian blood and other tissues. Anal Biochem 1969; 27:502-522.
20. Bergmeyer HU, Horder M, Rej R: Interna-tional Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransfer-ase, EC 2.6.1.2). J Clin Chem Clin Biochem 1986; 24:481-495.
21. Bais R, Philcox M: Approved recommenda-tion on IFCC methods for the measurement of catalytic concentration of enzymes. Part 8. IFCC Method for Lactate Dehydrogenase (L-Lactate: NAD+Oxidoreductase, EC 1.1.1.27). International Federation of Clinical Chem-istry (IFCC). Eur J Clin Chem Clin Biochem 1994; 32: 639-655.
22. Reddy MC, Koneru B, Soni S, Patel D: 31P nuclear magnetic resonance study of phos-pholipids in ischemia/reperfusion injury in a rat fatty liver model. Transplantation 1996; 61:1151-1155.
23. Teramoto K, Bowers JL, Kruskal JB, Clouse ME: Hepatic microcirculatory changes after reperfusion in fatty and normal liver trans-plantation in the rat. Transplantation 1993; 56: 1076-1082.
24. Selzner M, Clavien PA: Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21:105-113.
25. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM: Effect of ischemia-reper-fusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplanta-tion 2001; 72:1625-1631.
26. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al: 3-month and 12-month mortality after first liver trans-plant in adults in Europe: predictive models for outcome. Lancet 2006; 367:225-232.
27. Afonso RC, Hidalgo R, Paes AT, Zurstrassen MP, Fonseca LE, Pandullo FL, et al: Impact of cumulative risk factors for expanded cri-teria donors on early survival after liver transplantation. Transplant Proc 2008; 40: 800-801.
28. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, et al: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996; 13: 18-19.
29. Nardo B, Caraceni P, Pasini P, Domenicali M, Catena F, Cavallari G, et al: Increased generation of reactive oxygen species in iso-lated rat fatty liver during postischemic re-oxygenation. Transplantation 2001; 71: 1816-1820.
30. Lehmann TG, Wheeler MD, Schwabe RF, Connor HD, Schoonhoven R, Bunzendahl H, et al: Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat. He-patology 2000; 32:1255-1264.
31. Choi S, Noh J, Hirose R, Ferell L, Bedolli M, Roberts JP, et al: Mild hypothermia provides significant protection against ischemia/re-perfusion injury in livers of obese and lean rats. Ann Surg 2005; 241: 470-476.
32. Schauer RJ, Gerbes AL, Vonier D, Meissner H, Michl P, Leiderer R, et al: GSH protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann Surg 2004; 239: 220-231.
33. Lauterburg BH, Adams JD, Mitchell JR: He-patic GSH homeostasis in the rat: efflux ac-counts for GSH turnover. Hepatology 1984; 4:586-590.
34. Bilzer M, Lauterburg BH: GSH metabolism in activated human neutrophils: stimulation of GSH synthesis and consumption of GSH by reactive oxygen species. Eur J Clin Invest 1991; 21:316-322.
35. Aebi S, Assereto R, Lauterburg BH: High-dose intravenous GSH in man: pharmacoki-netics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest 1991; 21:103-110.
36. Akerboom TP, Gartner M, Sies H: Cellular hydroperoxide metabolism: the roles of GSH peroxidases and of catalase in liver. Bull Eur Physiopathol Respir 1981; 17(suppl):221-227.
37. Dickinson DA, Forman HJ: GSH in defense and signaling: lessons from a small thiol. Ann NY Acad Sci 2002; 973:488-504.
38. Seifalian AM, Piasecki C, Agarwal A, David-son BR: The effect of graded steatosis on flow in the hepatic parenchymal microCirculation. Transplantation 1999; 68:780-784.
39. Serkova N J, Jackman M, Brown JL, Liu T, Hi-rose R, Roberts JP, et al: Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 2006; 44: 956-962.
40. Yamagami K, Hutter J, Yamamoto Y, Schau-er RJ, Enders G, Leiderer R, et al: Synergistic effects of brain death and liver steatosis on the hepatic microcirculation. Transplanta-tion 2005; 80:500-505.